Delhi's All India Institute of Medical Sciences to start a clinical trial of Bharat Biotech's Covid-19 vaccine Covaxin on 50 children. Until now, AIIMS Patna has started the trials at the age of 12-18 years. After this, the trial will be conducted on the age group 6-12 years and 2-6 years. Watch video to know more about the story.
- Category
- Asia
- Tags
- Bharatbiotech, China, Coronavirus In India
Sign in or sign up to post comments.
Be the first to comment